The Sabin Vaccine Institute has launched a multi-site Phase 2 clinical trial in the U.S. for its Marburg vaccine candidate, ...

Serosurveys have expanded our understanding of infectious diseases in Africa, revealing the true burden of pathogens beyond ...

EQS-News: GeoVax, Inc. / Key word (s): Financial GeoVax Receives USPTO Notice of Allowance for Marburg Hemorrhagic Fever Vaccine Patent 09.04.2025 / 15:07 CET/CEST The issuer is solely responsible ...

At Africa's first global AI summit, leaders and experts gathered in Kigali to discuss how AI can boost the continent's ...

The Sabin Vaccine Institute has launched a multi-site Phase 2 clinical trial in the U.S. for its Marburg vaccine candidate, administering doses to the ...

Marburg outbreaks and isolated cases have previously been reported in Tanzania, Equatorial Guinea, Angola, Congo, Kenya, South Africa, Uganda and Ghana. The virus was first identified in 1967 ...

Africa CDC supported national responses to multiple major public health emergencies, including the mpox outbreak in 20 member states and the Marburg virus disease in Rwanda. Africa CDC declared mpox a ...

The Marburg virus, similar to Ebola in its lethality ... the Centres for Disease Control and Prevention (CDC) and the Africa CDC. These collaborations have facilitated the exchange of information ...

Dr. Ngashi Ngongo, the Principal Advisor to the Director General of Africa CDC on Programs, represented H.E. Dr. Jean Kaseya at the official handover ceremony in Luanda.